TRUEPILOT

Details for Australian Trade Mark No. 1160539 (hide)

Owner Bristol-Myers Squibb Company a Delaware corporation

Service Spruson & Ferguson

Filing Date 8 February 2007

Classes

Class 5 Pharmaceutical preparations for human use for the treatment and prevention of obesity, diabetes, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection; pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants, and pharmaceutical antibodies; diagnostic pharmaceutical preparations for human use for increasing the heart rate and contrast imaging agents; a syringe pre-filled with a pharmaceutical product for human use

Event Publications

1 March 2007 Application filed

7 June 2007 Application Accepted

13 September 2007 Opposition Filed

  FRESENIUS KABI AG has filed an opposition against Bristol-Myers Squibb Company a Delaware corporation.

26 June 2008 Opposition Withdrawn

  The opposition of FRESENIUS KABI AG against Bristol-Myers Squibb Company a Delaware corporation has been withdrawn.

26 June 2008 Application Withdrawn

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the ATMOSS Australian Trade Mark On-line Search System.

Next and Previous Trademarks/Applications

1160540-ERGOTROL

1160538